Madagascar vs Venezuela, Bolivarian Republic of: Previously treated cases tested for RR-/MDR-TB
Madagascar
69.0%
in 2024
Venezuela, Bolivarian Republic of
70.0%
in 2024
Madagascar rank
134th
Venezuela, Bolivarian Republic of rank
131st
Previously treated cases tested for RR-/MDR-TB over time
- Madagascar
- Venezuela, Bolivarian Republic of
How they compare
Venezuela, Bolivarian Republic of currently reports 70.0% against 69.0% in Madagascar, a difference of 1.0%.
The two have swapped places 6 times across 19 shared years of data; in 2006 it was Venezuela, Bolivarian Republic of ahead.
Madagascar ranks 134th and Venezuela, Bolivarian Republic of ranks 131st of 180 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Venezuela, Bolivarian Republic of in 2.
Head to head by decade
| Decade | Madagascar | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.0% | 28.2% | 25.2% | Venezuela, Bolivarian Republic of |
| 2010s | 18.3% | 36.8% | 18.5% | Venezuela, Bolivarian Republic of |
| 2020s | 56.0% | 52.6% | 3.4% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Madagascar or Venezuela, Bolivarian Republic of?
- Venezuela, Bolivarian Republic of, at 70.0% against 69.0% in Madagascar as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Madagascar and Venezuela, Bolivarian Republic of?
- 1.0%, with Venezuela, Bolivarian Republic of ahead.
- How many years of comparable data are there for Madagascar and Venezuela, Bolivarian Republic of?
- 19 years are reported by both, from 2006 to 2024.
- How do Madagascar and Venezuela, Bolivarian Republic of rank globally for previously treated cases tested for rr-/mdr-tb?
- Madagascar ranks 134th and Venezuela, Bolivarian Republic of ranks 131st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.